Compounding Pharmacy Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2025

Compounding Pharmacy Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ -- Compounding Pharmacy Market 2019

Wiseguyreports.Com adds “Compounding Pharmacy Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Compounding Pharmacy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Compounding Pharmacy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can’t be met by commercially available drugs. For example:
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.
A person may be allergic to one of the ingredients in the commercial version of a drug.
A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.
Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2017 is about 34%.
Compounding Pharmacy is widely used for consumers aged 18 and younger, consumers aged 19 to 44, consumers aged 45 to 64, consumers aged 65 and older. The most proportion of compounding pharmacy is consumers aged 45 to 64, and the proportion in 2017 is 40.7%.
North America is the largest market for compounding pharmacy, with a market share nearly 57% in 2017. Following North America, Europe is the second largest market with the consumption market share of 25%.
Market competition is not intense Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, Advanced Pharma, PharMEDium Services are the leaders of the industry, with high-end customers in the industry.
In 2018, the global Compounding Pharmacy market size was 10300 million US$ and it is expected to reach 12800 million US$ by the end of 2025, with a CAGR of 2.8% during 2019–2025.

This report focuses on the global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Compounding Pharmacy development in United States, Europe and China.

The key players covered in this study
Fagron
Wedgewood Pharmacy
CAPS
Fresenius Kabi
Advanced Pharma
PharMEDium Services
Cantrell Drug
Dougherty’s Pharmacy
Institutional Pharmacy Solutions
Lorraine’s Pharmacy
Triangle Compounding Pharmacy
Village Compounding Pharmacy
Olympia Pharmacy

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3832484-global-compounding-pharmacy-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into
Pharmaceutical Ingredient Alteration (PIA)
Pharmaceutical Application Alteration (PAA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Specialized Animal Pharmaceutical Manufacturing (SAPM)

Market segment by Application, split into
18 and Younger
19 to 44
45 to 64
65 and Older

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Key Stakeholders
Compounding Pharmacy Manufacturers
Compounding Pharmacy Distributors/Traders/Wholesalers
Compounding Pharmacy Subcomponent Manufacturers
Industry Association
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3832484-global-compounding-pharmacy-market-size-status-and-forecast-2019-2025

Major Key Points in Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Compounding Pharmacy Market Size Growth Rate by Type (2014–2025)
1.4.2 Pharmaceutical Ingredient Alteration (PIA)
1.4.3 Pharmaceutical Application Alteration (PAA)
1.4.4 Currently Unavailable Pharmaceutical Manufacturing (CUPM)
1.4.5 Pharmaceutical Dosage Alteration (PDA)
1.4.6 Specialized Animal Pharmaceutical Manufacturing (SAPM)
1.5 Market by Application
1.5.1 Global Compounding Pharmacy Market Share by Application (2014–2025)
1.5.2 18 and Younger
1.5.3 19 to 44
1.5.4 45 to 64
1.5.5 65 and Older
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Compounding Pharmacy Market Size
2.2 Compounding Pharmacy Growth Trends by Regions
2.2.1 Compounding Pharmacy Market Size by Regions (2014–2025)
2.2.2 Compounding Pharmacy Market Share by Regions (2014–2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

….

12 International Players Profiles
12.1 Fagron
12.1.1 Fagron Company Details
12.1.2 Company Description and Business Overview
12.1.3 Compounding Pharmacy Introduction
12.1.4 Fagron Revenue in Compounding Pharmacy Business (2014–2019)
12.1.5 Fagron Recent Development
12.2 Wedgewood Pharmacy
12.2.1 Wedgewood Pharmacy Company Details
12.2.2 Company Description and Business Overview
12.2.3 Compounding Pharmacy Introduction
12.2.4 Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2014–2019)
12.2.5 Wedgewood Pharmacy Recent Development
12.3 CAPS
12.3.1 CAPS Company Details
12.3.2 Company Description and Business Overview
12.3.3 Compounding Pharmacy Introduction
12.3.4 CAPS Revenue in Compounding Pharmacy Business (2014–2019)
12.3.5 CAPS Recent Development
12.4 Fresenius Kabi
12.4.1 Fresenius Kabi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Compounding Pharmacy Introduction
12.4.4 Fresenius Kabi Revenue in Compounding Pharmacy Business (2014–2019)
12.4.5 Fresenius Kabi Recent Development
12.5 Advanced Pharma
12.5.1 Advanced Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Compounding Pharmacy Introduction
12.5.4 Advanced Pharma Revenue in Compounding Pharmacy Business (2014–2019)
12.5.5 Advanced Pharma Recent Development
12.6 PharMEDium Services
12.6.1 PharMEDium Services Company Details
12.6.2 Company Description and Business Overview
12.6.3 Compounding Pharmacy Introduction
12.6.4 PharMEDium Services Revenue in Compounding Pharmacy Business (2014–2019)
12.6.5 PharMEDium Services Recent Development
12.7 Cantrell Drug
12.7.1 Cantrell Drug Company Details
12.7.2 Company Description and Business Overview
12.7.3 Compounding Pharmacy Introduction
12.7.4 Cantrell Drug Revenue in Compounding Pharmacy Business (2014–2019)
12.7.5 Cantrell Drug Recent Development
12.8 Dougherty’s Pharmacy
12.8.1 Dougherty’s Pharmacy Company Details
12.8.2 Company Description and Business Overview
12.8.3 Compounding Pharmacy Introduction
12.8.4 Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2014–2019)
12.8.5 Dougherty’s Pharmacy Recent Development

Continued....

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.